Tobias Else, MD

 Tobias Else
Associate Professor
Drew O'Donoghue Research Professor of Adrenal Cancer
Department of Internal Medicine
Chief Division of Genetic Medicine Comprehensive Clinical Care Center for von Hippel-Lindau Disease & Center of Excellence, Pheochromocytoma-Paraganglioma Alliance
Available to mentor
Tobias Else, MD
Tobias Else
Associate Professor
  • About
  • Qualifications
  • Center Memberships
  • Recent Publications

  • Manage Your Profile

    • About

    Dr. Else’s primary appointment is with the Division of Metabolism, Endocrinology and Diabetes. He received his MD degree from the University of Hamburg, Germany. He pursued his clinical training at the University of Hamburg (Residency: Internal Medicine) and the University of Michigan (Residency: Internal Medicine, Fellowship: Endocrinology). His main research interests are the genetics of endocrine tumors. Dr. Else’s clinical practice focuses on the care for patients with benign and malignant endocrine tumors, particularly pheochromocytoma, adrenocortical tumors and neuroendocrine tumors as well as accompanying hormone excess syndromes (e.g Cushing syndrome, primary aldosteronism). Dr. Else has a particular interest in taking care of patients with hereditary syndromes that predispose to the development of endocrine tumors (e.g. Multiple Endocrine Neoplasia (MEN) type 1, MEN2A & MEN2B, Hereditary Paraganglioma Syndrome). He attends the Multidisciplinary Endocrine Oncology Clinic, where patients with tumors receive diagnostic procedures and treatment. In addition he is part of the Cancer Genetics Clinic, which evaluates patients for hereditary syndromes and also facilitates regular exams and surveillance for patients at risk for endocrine tumors.

    Qualifications
    • Metabolism, Endocrinology and Diabetes Fellowship
      University of Michigan, Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes (MEND), Ann Arbor, United States
      2010 - 2014
      Other
    • Internal Medicine Residency
      University of Michigan, Department of Internal Medicine, United States
      2008 - 2010
      Residency
    • MD
      University of Hamburg, Martinistrasse 52, Hamburg, 20246, Germany
      1993 - 2000

    Center Memberships
    • Center Member
      Caswell Diabetes Institute
    • Center Member
      Rogel Cancer Center

    Recent Publications

     See All Publications
    • Journal Article
      Assessing Patient Characteristics in Neuroendocrine Tumor Research: A Comparison of the NET-PRO Study to SEER Population-Based Data
      O’Rorke MA, McDowell BD, Xu T, DeCook RR, Gryzlak BM, Rudzianski NJ, Serrano KC, Wehrheim AM, Grewal US, Chandrasekharan C, Dillon JS, Halfdanarson TR, Schnell MJ, Witter CL, Gamblin TC, Kazmi S, Cowell LG, Else T, Soares HP, Sukrithan V, Chandaka S, Sanoff HK, He FC, Geller DA, Ramirez RA, Liu M, Lancaster W, Mailman JA, Moran H, Wahmann M, Gellerman E, Chrischilles EA. Endocrine, 2026 Dec 1; 91 (1): DOI:10.1007/s12020-026-04611-w
      PMID: 42043735
    • Journal Article
      Primary aldosteronism
      Vaidya A, Kline GA, Mulatero P, Turcu AF, Williams TA, Wu VC, Yang J, Zennaro MC, Lacroix A. Nature Reviews Disease Primers, 2026 Dec 1; 12 (1): DOI:10.1038/s41572-026-00714-w
      PMID: 41879587
    • Presentation
      POT1 Tumor Predisposition: Experience and Thoughts on a Young Syndrome
      Else T. 2026 Oct 26;
    • Presentation
      Diagnosis and therapy of glucocorticoid-induced adrenal insufficiency
      Else T. 2026 Oct 26;
    • Presentation
      Endocrine Oncology – Focus on Hereditary Cancer Syndromes
      Else T. 2026 Oct 26;
    • Presentation
      Genetics in Endocrine Oncology: Essential Principles and Evolving Practice
      Else T. 2026 Oct 26;
    • Presentation
      POT1 Tumor Predisposition: Mechanism, Cancer Risk, and Local Experience
      Else T. 2026 Oct 26;
    • Presentation
      Our Cancer Genetics Clinic experience with POT1 cancer predisposition
      Else T. 2026 Jul 22;